WINDTREE THERAPEUTICS INC /DE/ Quarterly Income Tax Expense (Benefit) in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Windtree Therapeutics Inc /De/ quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2020 to Q2 2024.
  • Windtree Therapeutics Inc /De/ Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $197K.
  • Windtree Therapeutics Inc /De/ annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Windtree Therapeutics Inc /De/ annual Income Tax Expense (Benefit) for 2022 was -$1.37M, a 86.3% increase from 2021.
  • Windtree Therapeutics Inc /De/ annual Income Tax Expense (Benefit) for 2021 was -$9.99M.
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $197K +$197K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $114K +$114K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q2 2023 $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $0 +$8.33M Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q3 2021 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$8.33M -$8.33M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.